Hepatitis A



Comparative Immunogenicity Study of Two Hepatitis A Vaccines


Condition:   Hepatitis A
Intervention:   Biological: Hepatitis A Vaccine
Sponsors:   China National Biotec Group Company Limited;   Shanxi Provincial Center for Disease Control and Prevention (China)
Enrolling by invitation



A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule)


Condition:   Hepatitis E
Intervention:   Biological: Recombinant Hepatitis E Vaccine (Escherichia Coli)
Sponsor:   Xiamen Innovax Biotech Co., Ltd
Active, not recruiting


Hepatitis C Testing in VA Community-Based Outpatient Clinics


Condition:   Hepatitis C
Intervention:   Other: QI
Sponsor:   VA Office of Research and Development
Completed


This Study Will Evaluate the Persistence of Hepatitis A Antibodies, 8 Years and 10 Years Later, in Children Who Had Received Havrix at Selected Health Centres of Panama in 2007-2008


Condition:   Hepatitis A Vaccine
Intervention:   Procedure: Blood sample collection
Sponsor:   GlaxoSmithKline
Recruiting


The Hepatitis Delta International Network


Condition:   Hepatitis D
Intervention:  
Sponsors:   HepNet Study House, German Liverfoundation;   German Center for Infection Research
Recruiting


Immune Cell Dysfunction in Severe Alcoholic Hepatitis


Condition:   Hepatitis
Intervention:  
Sponsor:   Basildon and Thurrock University Hospitals NHS Foundation Trust
Recruiting


Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico


Condition:   Hepatitis A
Intervention:   Other: Data collection
Sponsor:   GlaxoSmithKline
Completed


Undiagnosed Hepatitis C Infection in an Urban Hospital


Condition:   Hepatitis C
Intervention:   Other: Observation only, no intervention
Sponsors:   Temple University;   Janssen Services, LLC
Completed


Analysis of Trends Over Time of Hepatitis Related Incidence in Panama


Condition:   Hepatitis
Intervention:   Other: Epidemiologic Surveillance System of the Ministry of Health of Panama
Sponsor:   GlaxoSmithKline
Completed


A Study of 2 Doses of VAQTA™ in Healthy Children 12 to 23 Months of Age (V251-069)


Condition:   Hepatitis A Virus Infection
Intervention:   Biological: Hepatitis A Vaccine, Purified Inactivated (VAQTA™)
Sponsor:   Merck Sharp & Dohme Corp.
Completed


Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in Adults


Conditions:   Hepatitis B;   Hepatitis A
Interventions:   Biological: Twinrix;   Biological: Engerix-B;   Biological: Havrix;   Biological: HBVAXPRO;   Biological: Vaqta
Sponsor:   GlaxoSmithKline
Completed


Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)


Condition:   Hepatitis A Virus
Interventions:   Biological: Comparator: VAQTA™ (Hepatitis A vaccine);   Biological: Comparator: ProQuad™ (Measles, Mumps, Rubella and Varicella vaccine);   Biological: Comparator: Prevnar™ (Pneumococcal 7-Valent Conjugate vaccine)
Sponsor:   Merck Sharp & Dohme Corp.
Completed


Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule


Condition:   Hepatitis A
Intervention:   Biological: Havrix™
Sponsor:   GlaxoSmithKline
Completed


Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule


Condition:   Hepatitis A
Intervention:   Biological: Havrix™
Sponsor:   GlaxoSmithKline
Completed


Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age (V251-068)


Condition:   Hepatitis A Virus
Interventions:   Biological: Comparator: VAQTA™;   Biological: Comparator: Infanrix™;   Biological: Comparator: PedvaxHIB™
Sponsor:   Merck Sharp & Dohme Corp.
Completed


Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults


Conditions:   Hepatitis B;   Hepatitis A
Intervention:   Biological: Twinrix™
Sponsor:   GlaxoSmithKline
Completed


Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc


Conditions:   Hepatitis B;   Hepatitis A
Interventions:   Biological: TWINRIX™;   Biological: Engerix™-B;   Biological: HAVRIX™;   Biological: HB VAX PRO™;   Biological: Vaqta™
Sponsor:   GlaxoSmithKline
Completed


LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers


Condition:   Hepatitis B
Interventions:   Biological: Engerix™ -B;   Biological: Hepatitis B immunoglobulin (HBIg)
Sponsor:   GlaxoSmithKline
Completed



Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age


Condition:   Hepatitis A
Intervention:   Biological: Hepatitis A
Sponsor:   GlaxoSmithKline
Completed


Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months


Condition:   Hepatitis A
Interventions:   Biological: Havrix™;   Biological: Infanrix™;   Biological: ActHIB™
Sponsor:   GlaxoSmithKline
Completed


Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children


Condition:   Hepatitis A
Interventions:   Biological: Havrix®;   Biological: M-M-R®II;   Biological: VARIVAX®
Sponsor:   GlaxoSmithKline
Completed


Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared


Conditions:   Hepatitis B;   Hepatitis A
Interventions:   Biological: Twinrix™ Adult;   Biological: Twinrix™ Junior
Sponsor:   GlaxoSmithKline
Completed


Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years


Conditions:   Hepatitis B;   Hepatitis A
Interventions:   Biological: Twinrix™ Adult;   Biological: Twinrix™ Junior
Sponsor:   GlaxoSmithKline
Completed

Refine Your Search Advanced Search